Natural Biocon (India) Ltd
₹ 12.2
1.42%
30 Aug
- close price
About
Incorporated in 1992, Natural Biocon Ltd trades in chemicals, natural extracts, agricultural produce and commodities[1]
Key Points
- Market Cap ₹ 13.8 Cr.
- Current Price ₹ 12.2
- High / Low ₹ 14.8 / 8.33
- Stock P/E 35.5
- Book Value ₹ 10.9
- Dividend Yield 0.00 %
- ROCE 1.85 %
- ROE 1.22 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.12 times its book value
- Debtor days have improved from 229 to 131 days.
- Company's working capital requirements have reduced from 227 days to 24.3 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -11.9%
- Promoter holding is low: 9.36%
- Company has a low return on equity of 1.10% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.15 | 1.04 | 0.45 | 0.00 | 0.13 | 0.48 | 1.25 | 13.53 | 17.76 | |
0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1.00 | 13.30 | 17.30 | |
Operating Profit | 0.00 | 0.11 | 1.00 | 0.11 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.46 |
OPM % | 0.00% | 73.33% | 96.15% | 24.44% | 0.00% | 18.75% | 20.00% | 1.70% | 2.59% | |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.00 | 0.11 | 1.00 | 0.12 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.46 |
Tax % | 27.27% | 30.00% | 41.67% | 166.67% | 22.22% | 28.00% | 30.43% | |||
0.00 | 0.08 | 0.70 | 0.07 | -0.08 | 0.00 | 0.07 | 0.18 | 0.15 | 0.39 | |
EPS in Rs | 0.00 | 0.07 | 0.62 | 0.06 | -0.07 | 0.00 | 0.06 | 0.16 | 0.13 | 0.34 |
Dividend Payout % | 0.00% | 0.00% | 81.21% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 98% |
3 Years: | 370% |
TTM: | 850% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | % |
TTM: | 56% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -21% |
1 Year: | 24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 |
Reserves | 0.00 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 |
0.00 | 0.00 | 0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | |
0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | |
Total Liabilities | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |
CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | |
Total Assets | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 |
Cash Flows
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | |
0.00 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0.00 | -0.02 | -0.09 | |
Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | 0.00 | 0.17 | 0.19 | -0.21 |
Ratios
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 357.98 | 632.67 | 1,460.00 | 372.60 | 183.96 | 131.38 | |
Inventory Days | 821.25 | 547.50 | 192.99 | 4.61 | |||||
Days Payable | 0.00 | 0.00 | 213.97 | 117.92 | |||||
Cash Conversion Cycle | 821.25 | 547.50 | 357.98 | 632.67 | 1,460.00 | 372.60 | 162.98 | 18.07 | |
Working Capital Days | 7,665.00 | 2,238.67 | 572.07 | 1,346.44 | 4,829.23 | 479.06 | 178.12 | 24.28 | |
ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | 0.00% | 0.73% | 2.03% | 1.85% |
Documents
Announcements
- Board Meeting Intimation for Meeting Of Board To Be Held On Thursday, September 05, 2024 1d
- Unaudited Financial Result For The Quarter Ended On June 30, 2024 14 Aug
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Held On August 14,2024 14 Aug
- Board Meeting Intimation for Meeting Of Board To Be Held On August 14, 2024 9 Aug
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 30 Jul
Business Overview:[1]
Company is in the business of extracting, procuring, crushing, separating, trading and dealing in plants, seeds, agriculture produce
and all types of vegetation, juices, and alkaloids viz. nicotine, caffeine, tannin, morphine, codeine, strychnine, nuxvomicase, brucine and manufacture of all types of Agro chemicals, for barely malt, maltose, malt sugar, and its derivatives. Company also plans to venture into agriculture produce, marine, solar and infrastructure